Interventional News

Data from a new study have found that venous leak embolization yields additional clinical improvement and treatment potential in patients with vasculogenic erectile dysfunction resistant to phosphodiesterase-5-inhibitors (PDE5i) due to mixed arterio-venous disease. Nicolas Diehm Hanno Hoppe CardioVascular and Interventional Radiology (CVIR) https://lnkd.in/eNGAaQ7i

WAVE trial six-month data show “tremendous” results for WRAPSODY The six-month results of the WAVE (WRAPSODY Arteriovenous Access Efficacy) pivotal trial have reported superior target lesion primary patency (TLPP) with the WRAPSODY (Merit Medical) cell-impermeable endoprosthesis when compared to percutaneous transluminal angioplasty (PTA) when used in failing arteriovenous fistulas (AVF). Experts note that based on these results, covered stents could potentially be a first-line treatment in dedicated lesion sites, ushering in an era of tailored therapy for dialysis patients.   Read more: https://lnkd.in/eFQgmxdj #InnovatingHealthcare This video, intended for our audience in countries where WRAPSODY is CE marked, is sponsored by Merit Medical Systems, Inc.

Read the top 10 most read stories in November 2024 📰 Andreas Adam Muneeb Ahmed iVascular Boston Scientific Damascelli Bruno Medtronic Fluidx Medical Technology, Inc. Society of Interventional Oncology https://lnkd.in/ebqf8MEg

Vivance has recently announced that the next trial phase of the wearable peritoneal dialysis (PD) device, Viva Kompact, has successfully concluded. The study was conducted at Singapore General Hospital, and was shared at the American Society of Nephrology (ASN) Kidney Week (23–27 October, San Diego, USA). To learn more about this, follow the link below and read the full article!

Discussing the Allia IGS 7 (GE HealthCare) and its role within his daily practice, Bjoern Suckow (Dartmouth Health, Lebanon, USA) shares how the system has “technologically revolutionised” the way he and his team plan, visualise and perform complex procedures. Sponsored by GE HealthCare https://t.ly/pHX0H

AngioDynamics has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for the NanoKnife system for prostate tissue ablation. The company received clearance for the system following the completion of the pivotal PRESERVE clinical study in September which met its primary effectiveness endpoint for the ablation of prostate tissue in patients with intermediate-risk prostate cancer. https://lnkd.in/e8f-_2TH

The Society of Interventional Radiology (SIR) has announced that Charles Ray Jr. (Salt Lake City, USA) and Brian Funaki (Chicago, USA) have been selected as the incoming co-editors-in-chief of SIR’s flagship publication, the JOURNAL OF VASCULAR & INTERVENTIONAL RADIOLOGY (JVIR). https://t.ly/u9fjh

IceCure Medical has today announced interim results from the company’s Icesecret study of cryoablation for patients with small renal masses who cannot be offered kidney preserving surgery. Among the findings, it was reported that in 91 patients (approximately 82%) no tumour recurrence was observed. https://lnkd.in/e4cji_6T

Centerline Biomedical has announced that it has received the US Food and Drug Administration (FDA) 510(k) approval for its new Intra-Operative Positioning System (IOPS) guidewire handle. Vikash Goel https://lnkd.in/eDP28tfu

The Society of Interventional Radiology has announced that Eve Lee, MBA, CAE, executive director at the American Orthotic and Prosthetic Association (AOPA), will join the organisation on 27 January, 2025, as its new chief executive officer. https://lnkd.in/eXwtihxv